BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12840669)

  • 41. Clinical applications of advances in the genetics of IBD.
    Sartor RB
    Rev Gastroenterol Disord; 2003; 3 Suppl 1():S9-17. PubMed ID: 12684584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of the CARD15/NOD2 gene and the impact on management and treatment of Crohn's disease patients.
    Török HP; Glas J; Lohse P; Folwaczny C
    Dig Dis; 2003; 21(4):339-45. PubMed ID: 14752224
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different?
    Büning C; Molnar T; Nagy F; Lonovics J; Weltrich R; Bochow B; Genschel J; Schmidt H; Lochs H
    World J Gastroenterol; 2005 Jan; 11(3):407-11. PubMed ID: 15637755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Physiopathology of inflammatory bowel diseases: new biological tools for disease diagnosis and monitoring?].
    Desreumaux P; Bourreille A; Colombel JF
    Gastroenterol Clin Biol; 2003 Mar; 27(3 Suppl):S81-6. PubMed ID: 12704300
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort.
    Gearry RB; Roberts RL; Burt MJ; Frampton CM; Chapman BA; Collett JA; Shirley P; Allington MD; Kennedy MA; Barclay ML
    Inflamm Bowel Dis; 2007 Oct; 13(10):1220-7. PubMed ID: 17538984
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inflammatory bowel disease.
    Marteau P
    Endoscopy; 2002 Jan; 34(1):63-8. PubMed ID: 11778131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. What are the major arguments in favour of the genetic susceptibility for inflammatory bowel disease?
    Tamboli CP; Cortot A; Colombel JF
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):587-92. PubMed ID: 12840667
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The genesis of IBD genetics.
    Lewis JD
    Gastroenterology; 2002 Dec; 123(6):2148-9. PubMed ID: 12454871
    [No Abstract]   [Full Text] [Related]  

  • 49. Advances in the genetics of inflammatory bowel disease.
    Cho JH
    Curr Gastroenterol Rep; 2004 Dec; 6(6):467-73. PubMed ID: 15527676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CARD15/NOD2 analyses in spondylarthropathy.
    Miceli-Richard C; Zouali H; Lesage S; Thomas G; Hugot JP; Said-Nahal R; Breban M
    Arthritis Rheum; 2002 May; 46(5):1405-6. PubMed ID: 12115249
    [No Abstract]   [Full Text] [Related]  

  • 51. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.
    Zheng CQ; Hu GZ; Zeng ZS; Lin LJ; Gu GG
    World J Gastroenterol; 2003 Aug; 9(8):1646-56. PubMed ID: 12918095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular discoveries alter our view of inflammatory bowel disease. A review from scientific, clinical, and laboratory perspectives.
    Staros EB
    Am J Clin Pathol; 2003 Apr; 119(4):524-39. PubMed ID: 12710125
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics of inflammatory bowel disease: the beginning of the end or the end of the beginning?
    Annese V; Latiano A; Andriulli A
    Dig Liver Dis; 2003 Jun; 35(6):442-9. PubMed ID: 12868683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetics of inflammatory bowel disease: scientific and clinical implications.
    Satsangi J; Morecroft J; Shah NB; Nimmo E
    Best Pract Res Clin Gastroenterol; 2003 Feb; 17(1):3-18. PubMed ID: 12617879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical relevance of advances in genetics and pharmacogenetics of IBD.
    Ahmad T; Tamboli CP; Jewell D; Colombel JF
    Gastroenterology; 2004 May; 126(6):1533-49. PubMed ID: 15168365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The genetics of inflammatory bowel disease.
    Baburajan B; Parkes M
    Hosp Med; 2003 Oct; 64(10):599-602. PubMed ID: 14584240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Molecular biology background of inflammatory bowel disease].
    Miheller P; Muzes G; Galamb O; Molár B; Tulassay Z
    Orv Hetil; 2006 Jul; 147(30):1395-403. PubMed ID: 16977777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 59. Update on the genetics of inflammatory bowel disease.
    Duerr RH
    J Clin Gastroenterol; 2003; 37(5):358-67. PubMed ID: 14564181
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotype-determining genes in inflammatory bowel disease.
    Ahmad T
    Novartis Found Symp; 2004; 263():17-29; discussion 29-40, 211-8. PubMed ID: 15669632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.